CUC Resultados de beneficios anteriores
Pasado controles de criterios 5/6
CUC has been growing earnings at an average annual rate of 18.4%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 23.3% per year. CUC's return on equity is 12.5%, and it has net margins of 9.1%.
Información clave
18.4%
Tasa de crecimiento de los beneficios
7.6%
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare | 7.9% |
| Tasa de crecimiento de los ingresos | 23.3% |
| Rentabilidad financiera | 12.5% |
| Margen neto | 9.1% |
| Última actualización de beneficios | 30 Sep 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
CUC Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Oct 31
Does CUC (TSE:9158) Have A Healthy Balance Sheet?
Oct 29CUC (TSE:9158) May Have Issues Allocating Its Capital
Sep 04CUC Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 26Is CUC (TSE:9158) Using Too Much Debt?
Jul 17Take Care Before Jumping Onto CUC Inc. (TSE:9158) Even Though It's 27% Cheaper
Jun 15Results: CUC Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 28More Unpleasant Surprises Could Be In Store For CUC Inc.'s (TSE:9158) Shares After Tumbling 35%
Apr 27Desglose de ingresos y gastos
Cómo gana y gasta dinero CUC. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 39,290 | 3,565 | 14,343 | 0 |
| 30 Jun 24 | 35,959 | 3,079 | 13,129 | 0 |
| 31 Mar 24 | 33,025 | 2,595 | 9,833 | 0 |
| 31 Dec 23 | 31,133 | 1,779 | 11,432 | 0 |
| 30 Sep 23 | 31,862 | 1,952 | 10,802 | 0 |
| 30 Jun 23 | 32,737 | 1,992 | 10,459 | 0 |
| 31 Mar 23 | 35,210 | 2,423 | 10,015 | 0 |
| 31 Mar 22 | 35,314 | 2,707 | 8,788 | 0 |
| 31 Mar 21 | 16,606 | 1,100 | 5,711 | 0 |
Ingresos de calidad: 9158 has high quality earnings.
Margen de beneficios creciente: 9158's current net profit margins (9.1%) are higher than last year (6.1%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 9158's earnings have grown by 18.4% per year over the past 5 years.
Acelerando crecimiento: 9158's earnings growth over the past year (82.6%) exceeds its 5-year average (18.4% per year).
Beneficios vs. Industria: 9158 earnings growth over the past year (82.6%) exceeded the Healthcare industry 9.6%.
Rentabilidad financiera
Alta ROE: 9158's Return on Equity (12.5%) is considered low.